ARTV
Artiva Biotherapeutics Inc. (ARTV)
Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 30
+0.16
+5.1%
$
85.17M Market Cap
- P/E Ratio
0% Div Yield
79,926 Volume
- Eps
$ 3.14
Previous Close Day Range
3.1 3.3
Year Range
1.47 11.55
Want to track ARTV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ARTV ARTV Artiva Biotherapeutics Inc. 18 Nov 2025 | | - | - |
| ARTV ARTV Artiva Biotherapeutics Inc. 11 Nov 2025 | | - | - |
| ARTV ARTV Artiva Biotherapeutics Inc. 28 Aug 2025 | | - | - |
| ARTV ARTV Artiva Biotherapeutics Inc. 7 Aug 2025 | | - | - |
| ARTV ARTV Artiva Biotherapeutics Inc. 28 May 2025 | | - | - |
| ARTV ARTV Artiva Biotherapeutics Inc. 25 Mar 2025 | | - | - |
| ARTV ARTV Artiva Biotherapeutics Inc. 13 Nov 2024 | | - | - |
| ARTV ARTV Artiva Biotherapeutics Inc. 29 Aug 2024 | | - | - |
ARTV Earnings Reports FAQ
What is the earnings per share (EPS) for ARTV?
EPS data for ARTV is currently not available, as Artiva Biotherapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Artiva Biotherapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Artiva Biotherapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Artiva Biotherapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ARTV at this time, as Artiva Biotherapeutics Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
